Last update:

Oncology & Cancer news

Oncology & Cancer

Clinical trials confirm zolbetuximab's efficacy in gastric cancer

In Germany, around 17,000 people are diagnosed with gastric cancer every year. The disease is one of the leading causes of tumor-related deaths. This is due to late diagnosis and the rapid spread of tumor cells throughout ...

Oncology & Cancer

Lynch syndrome: New patient database of genetic condition aims to prevent cancer

A new database of all patients with Lynch syndrome aims to improve treatment and prevention for those at high-risk of cancer.

Oncology & Cancer

An AI-powered pipeline for personalized cancer vaccines

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses ...

Oncology & Cancer

Long-term study shows early prostate cancer surgery extended life

The survival rate of men with prostate cancer who had their entire prostate gland removed immediately after the tumor was detected increased by 17 percentage points compared with those who did not have treatment until the ...

Oncology & Cancer

Response to neoadjuvant chemo for breast cancer varies by sex

Both proportions and odds of pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) are numerically lower in men with breast cancer (BC) versus women with BC for each tumor subtype, according to a study published ...

Oncology & Cancer

What is a stool DNA test?

Many people with colon cancer experience no symptoms in the early stages of the disease. With time, though, the cancer cells can grow to invade and destroy normal tissue nearby. And cancerous cells can travel to other parts ...

Oncology & Cancer

Researchers investigate cancer cluster in Alabama town

Fruithurst is your quintessential small town. Located in Cleburne County, Alabama—just five miles on the other side of the Georgia state line—only a few hundred people call it home.

Oncology & Cancer

New gene target for aggressive lung cancer discovered

Northwestern Medicine scientists have identified and described a new gene that is responsible for activating an aggressive subtype of small-cell lung cancer, the P subtype, for which there is no current effective treatment.

Oncology & Cancer

Benefit of risk-based breast cancer screening is still unclear

The Austrian Institute for Health Technology Assessment (AIHTA) has analyzed whether risk-based breast cancer screening has advantages over the conventional age-based screening program. The central result: the current prediction ...

Oncology & Cancer

Researchers discover new molecular driver of retinoblastoma

Despite decades of medical advances, children who develop the pediatric eye cancer retinoblastoma often lose their vision or an eye due to a lack of specific, targeted therapies and a poor molecular understanding of the cancer. ...

Oncology & Cancer

Cancer cells adopt hitherto unknown state to facilitate metastasis

The ancient Egyptians, as described in the Ebers Papyrus, already knew that palpation—feeling for hardened lumps—can help diagnose breast cancer. Palpation is still an important element in early screening for breast cancer. ...